DONALD BARRY KOHN, MD
Medical Practice at Sunset Blvd, Los Angeles, CA
License number
California G60297
Category
Medical Practice
Type
Pediatric Hematology-Oncology
Address
Address
4650 W Sunset Blvd, Los Angeles, CA 90027
Phone
(323) 669-4559
(323) 660-1904 (Fax)
(323) 669-2337
(323) 644-8488 (Fax)
(323) 660-1904 (Fax)
(323) 669-2337
(323) 644-8488 (Fax)
Personal information
See more information about DONALD BARRY KOHN at radaris.comName
Address
Phone
17127 Brewer Rd, Grass Valley, CA 95949
15671 Williams St APT 60, Tustin, CA 92780
13162 Highway 8 Business, El Cajon, CA 92021
625 Keoncrest Dr, Ssf, CA 94080
30505 Flossmoor Way, Hayward, CA 94544
Professional information
See more information about DONALD BARRY KOHN at trustoria.com
Donald Barry Kohn, Los Angeles CA
Donald Barry Kohn, Los Angeles CA
Specialties:
Pediatrics, Pediatric Hematology-Oncology
Work:
Ucla Medical Group-W LA
200 Ucla Medical Plz, Los Angeles, CA 90095 University of California at Los Angeles
615 Charles E Young Dr E, Los Angeles, CA 90095
200 Ucla Medical Plz, Los Angeles, CA 90095 University of California at Los Angeles
615 Charles E Young Dr E, Los Angeles, CA 90095
Education:
University of Wisconsin at Madison (1982)
Donald Barry Kohn, Los Angeles CA
Donald Barry Kohn, Los Angeles CA
Specialties:
Pediatrician
Address:
4650 W Sunset Blvd, Los Angeles, CA 90027
Education:
University of Wisconsin, School of Medicine and Public Health - Doctor of Medicine
University of Wisconsin Hospital & Clinics - Residency - Pediatrics
University of Wisconsin Hospital & Clinics - Residency - Pediatrics
Board certifications:
American Board of Pediatrics Certification in Pediatrics
Dr. Donald B Kohn, Los Angeles CA - MD (Doctor of Medicine)
Dr. Donald B Kohn, Los Angeles CA - MD (Doctor of Medicine)
Specialties:
Pediatrics
Address:
UCLA Pediatric Hmtlgy/Onclgy
10833 Le Conte Ave SUITE A2-410, Los Angeles 90095
(310) 825-6708 (Phone)
10833 Le Conte Ave SUITE A2-410, Los Angeles 90095
(310) 825-6708 (Phone)
Certifications:
Pediatrics, 1988
Awards:
Healthgrades Honor Roll
Languages:
English
Hospitals:
UCLA Pediatric Hmtlgy/Onclgy
10833 Le Conte Ave SUITE A2-410, Los Angeles 90095
Ronald Reagan UCLA Medical Center
757 Westwood Plz, Los Angeles 90095
10833 Le Conte Ave SUITE A2-410, Los Angeles 90095
Ronald Reagan UCLA Medical Center
757 Westwood Plz, Los Angeles 90095
Education:
Medical School
University of Wisconsin / Madison
Graduated: 1982
University Of Wisconsin-Madison
National Institutes Of Health Clinical Center
University of Wisconsin / Madison
Graduated: 1982
University Of Wisconsin-Madison
National Institutes Of Health Clinical Center
Gene Therapy By Administration Of Genetically Engineered Cd34 Cells Obtained From Cord Blood
Gene Therapy By Administration Of Genetically Engineered Cd34 Cells Obtained From Cord Blood
US Patent:
6984379, Jan 10, 2006
Filed:
Apr 8, 1994
Appl. No.:
08/225478
Inventors:
Donald B. Kohn - Tarzana CA, US
R. Michael Blaese - Rockville MD, US
Craig A. Mullen - Sugar Land TX, US
Robert C. Moen - Mountain View CA, US
R. Michael Blaese - Rockville MD, US
Craig A. Mullen - Sugar Land TX, US
Robert C. Moen - Mountain View CA, US
Assignee:
Children's Hospital of LosAngeles - LosAngeles CA
The United States of America as represented by the Department of Health and Human Services - Washington DC
The United States of America as represented by the Department of Health and Human Services - Washington DC
International Classification:
A61K 48/00, C12N 15/63, C12N 15/74, C12N 15/00, C12N 5/00
US Classification:
424 9321, 424 932, 514 44, 435325, 4353201, 4352401, 4352402, 530350, 536 221, 536 231, 536 241
Abstract:
A method of providing a therapeutic effect in a human patient which comprises administering to the patient CD34+ cells obtained from cord blood. The CD34+ cells have been engineered with at least one nucleic acid sequence encoding a therapeutic agent. Such CD34+ cells may be engineered by transducing the cells with a retroviral vector including the nucleic acid sequence encoding the therapeutic agent. This method has been applied in treating newborn infants suffering from ADA deficiency.
Retroviral Vectors For Expression In Embryonic Cells
Retroviral Vectors For Expression In Embryonic Cells
US Patent:
5707865, Jan 13, 1998
Filed:
Dec 21, 1994
Appl. No.:
8/361112
Inventors:
Donald B. Kohn - Tarzana CA
Pia M. Challita - Sherman Oaks CA
Pia M. Challita - Sherman Oaks CA
International Classification:
C12N 510, C12N 516, C12N 1586
US Classification:
435325
Abstract:
Retroviral plasmid vectors which include an enhancer region obtained from a virus selected from the group consisting of Myeloproliferative Sarcoma Virus and polyoma virus, and a primer binding site obtained from murine retrovirus. The retroviral plasmid vector does not include a negative control region. The vector also may include a nucleic acid sequence which encodes demethylation of cytosine residues in the proviral LTR. Such plasmid vectors are especially useful in the generation of retroviral vector particles which may be expressed in embryonic cells, such as embryonic stem cells.